Resources Jobs

PROGRAM SCHOLAR - The Harvard Career Development Program in Translational Glycobiology: Bridging Glycoscience and Clinical Medicine

 
Florida International University is classified by Carnegie as a “R1: Doctoral Universities - Highest Research Activity” and recognized as a Carnegie Community Engaged university. It is a public research university with colleges and schools that offers bachelor’s, master’s and doctoral programs in fields such as business, engineering, computer science, international relations, architecture, law and medicine. As one of South Florida’s anchor institutions, FIU contributes almost $9 billion each year to the local economy and is ranked second in Florida in Forbes Magazine’s “America’s Best Employers” list. FIU graduates are consistently among the highest paid college graduates in Florida and are among the leaders of public and private organizations throughout South Florida. FIU is Worlds Ahead in finding solutions to the most challenging problems of our time. FIU emphasizes research as a major component of its mission with multiple state-of-the-art research facilities including the Wall of Wind Research and Testing FacilityFIU’s Medina Aquarius Program and the Advanced Materials Engineering Research Institute. FIU has awarded more than 220,000 degrees and enrolls more than 54,000 students in two campuses and centers including FIU Downtown on Brickell, FIU@I-75, the Miami Beach Urban Studios, and Tianjin, China. FIU also supports artistic and cultural engagement through its three museums: Patricia & Phillip Frost Art Museum, the Wolfsonian-FIU, and the Jewish Museum of Florida-FIU. FIU is a member of Conference USA and more than 400 student-athletes participating in 18 sports. For more information about FIU, visit http://www.fiu.edu/.
 
PROGRAM SCHOLAR
The Harvard Career Development Program in Translational Glycobiology: Bridging Glycoscience and Clinical Medicine
 
There are four main macromolecules of nature: the proteins, the lipids, the nucleic acids, and the glycans (carbohydrates). Though many people recognize that glycans play key roles in nutrition and in various diseases (e.g., diabetes), few people appreciate that glycans program a wide variety of biologic processes impacting both health and disease. There is a pressing need to expand our knowledge into how glycans affect human well-being, but there are very few biomedical scientists that have the needed education and skills for performing research into how glycans control key aspects of human biology. The key to bridging this translational chasm is to support the development of scientists with requisite interdisciplinary knowledge and experience by providing training in glycosciences concomitantly with education in human biology, altogether framed by an appreciation of human diseases and clinical urgency.
 
To meet this goal, the National Heart, Lung, Blood Institute (NHLBI) has funded a Career Development Program (K12 Program) at the Harvard Medical School, and this program is now available for recruitment of Program Scholars (trainees) at Florida International University (FIU). This program, the “Harvard Career Development Program in Translational Glycobiology” (Harvard ProTG), is a Harvard University-wide program (linking the Harvard Medical School Quadrangle (HMS Quad) together with all the major HMS teaching hospitals and the Harvard University Main Campus). With the recent opening of the Translational Glycobiology Institute at FIU (TGIF), the Program Scholar chosen will be trained within the TGIF, which currently houses the laboratories of two eminent glycobiologsts, Dr. Robert Sackstein and Dr. Chuck Dimitroff. It is expected that the Program Scholar will focus on the glycobiology of conditions related to the mission of the NHLBI (i.e., heart, blood, lung, and sleep disorders).
 
Minimum qualifications include a terminal doctoral degree as Ph.D., M.D., or M.D./PhD. Eligibility includes post-doctoral fellows that have completed at least two (2) years of research training, physicians who have completed residencies or fellowships in clinical specialties, and early stage faculty members.  Physicians who are in practice in any clinical specialty are also eligible to become a Program Scholar.
Individuals are not eligible for the Harvard ProTG if they:

  • Have simultaneously submitted or have an application pending peer review for any other federal career development award or a research project grant (R01). However, individuals may concurrently submit an application for an AHRQ or NIH Small Grant (R03) or Exploratory/Developmental Grants (R21);
  • Have simultaneously submitted or have an application pending peer review for any non-federal research grant, contract, or cooperative agreement over $100,000 in direct costs per year;
  • Have been or are currently a PD/PI on any other federal mentored career development awards;
  • Have been or are currently supported on an institutional K12 grant or KL2 (or similar grant);
  • Have been or are currently a PD/PI on a Federal research grant (such as R01, R29, P01) or subproject leaders on Program Project (P01) and Center Grants (P50); and/or
  • Have been or are currently a PD/PI on peer-reviewed non-federal research grants, contracts or cooperative agreements over $100,000 direct costs per year.
Qualified candidates are encouraged to apply to Job Opening ID 520164 at facultycareers.fiu.edu and attach a brief research proposal including references (not to exceed 5 pages), curriculum vitae (CV), NIH Biosketch and letter of reference/support.  Candidates will be requested to provide names and contact information for at least three references who will be contacted upon as determined by the hiring official. To receive full consideration, applications and required materials should be received by January 12, 2020. Review will continue until position is filled.
FIU is a member of the State University System of Florida and an Equal Opportunity, Equal Access Affirmative Action Employer all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.